| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 0.50% |
| NAV | ₹12.85 (29 Oct 2020) |
|---|---|
| Fund Started | 19 Oct 2018 |
| Fund Size | ₹56 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| PI Industries Ltd. | Chemicals | Equity | 5.3% |
| Astral Poly Technik Ltd. | Chemicals | Equity | 3.9% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 3.8% |
| Atul Ltd. | Chemicals | Equity | 3.3% |
| HDFC Bank Ltd. | Financial | Equity | 3.1% |
| SRF Ltd. | Diversified | Equity | 3.1% |
| Navin Fluorine International Ltd. | Chemicals | Equity | 2.9% |
| Crompton Greaves Consumer Electricals Ltd. | Cons Durable | Equity | 2.8% |
| Relaxo Footwears Ltd. | FMCG | Equity | 2.7% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 2.6% |
BOI AXA Midcap Tax Fund Series 2 Direct Growth is a Equity Mutual Fund Scheme launched by BOI AXA Mutual Fund. This scheme was made available to investors on 19 Oct 2018. Saurabh Kataria is the Current Fund Manager of BOI AXA Midcap Tax Fund Series 2 Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹56 Cr and the Latest NAV as of 29 Oct 2020 is ₹12.85.
The BOI AXA Midcap Tax Fund Series 2 Direct Growth is rated Moderately High risk.
The scheme seeks to generate capital appreciation over a period of ten years by investing predominantly in equity and equity-related securities of midcap companies along with income tax benefit.